Access to medicines

: Kristina Lybecker
: December 22, 2011

The Economics of Access to Medicines: Meeting the Challenges of Pharmaceutical Patents, Innovation, and Access for Global Health

Neglected diseases impose a tremendous burden on global health.  One that is disproportionally borne by the poor and vulnerable.  Each year more than 18... More »
: Access to medicines, Global, Global health, innovation, Intellectual property, Research papers
: Susan Huggett
: June 10, 2011

CBO report: further restricting DTC advertising may be bad for public health

Guest blog by Susan Huggett, President of Torre Lazur McCann Canada Periodically, there have been calls for greater limits on direct to consumer (DTC) advertising... More »
: Access to medicines, Articles, DTC advertising, innovation, USA
: Steven Lott
: October 24, 2010

Advancing Access to Newer Treatments for Atrial Fibrillation

Presentation at the Canadian Cardiovascular Society Congress, attended by Steven Lott, Siobhan Cavanaugh (Associate) and Wayne Taylor (ED, Cameron Institute).... More »
: Access to medicines, Atrial Fibrillation, Canada, Presentations
: Steven Lott
: August 11, 2010

Canada is slow to adopt innovative medicines, according to new study

According to a recently released report comparing international usage of prescription drugs, Canada ranks second-last (thirteenth out of 14 countries). The report... More »
: Access to medicines, Articles, Canada
: Elisabeth Fowler
: November 4, 2009

Accessing Drugs for Rare Diseases in Canada: The Patient Perspective

Elisabeth Fowler delivered the attached presentation at the Drug Information Association conference in Ottawa, Canada in November, 2009. The presentation covered... More »
: Access to medicines, Canada, Presentations, Rare Disorders
: Elisabeth Fowler
: September 20, 2009

How are new drugs developed?

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009. ... More »
: Access to medicines, Canada, innovation, Presentations
: Elisabeth Fowler
: September 20, 2009

Models of Public Engagement in Health Technology Assessment

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009. ... More »
: Access to medicines, Canada, Health Technology Assessment, Patient engagement, Presentations
: Elisabeth Fowler
: July 1, 2009

Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules

Journal of Law, Medicine and EthicsSummer 2009Kristina M. Lybecker, Colorado CollegeElisabeth Fowler, World Health Advocacy The tension between economic policy and... More »
: Access to medicines, Compulsory licensing, Global, Intellectual property, Research papers
: Steven Lott
: May 20, 2008

Patient-friendly summary of the WHO IGWG draft strategy

In August 2006 the World Health Organization (WHO) established the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG... More »
: Access to medicines, Global, innovation, Intellectual property, Reports
: cward
: April 1, 2007

Generic Drugs In Canada: A Policy Paper

This Report provides an overview of background information related to the pharmaceutical market both globally and within Canada, followed by a summary of the... More »
: Access to medicines, Canada, Generic medicines, Health policy, Reimbursement, Reports